Release Summary

Targeted Medical Pharma (OTCQB: TRGM) Reports promising Q2 2014 financial results. The company showed significant improvements in revenue, gross profit, and adjusted EBITDA compared to Q2 2013.

Targeted Medical Pharma, Inc.